IP Policy
$0 RoyaltiesUsers maintain 100% ownership of all generated intellectual property.

Cradle is an AI platform for protein engineering. Ideal for biotech R&D teams, it helps design and optimize protein sequences using generative machine learning.
Cradle is an AI platform that helps biologists and research teams design and optimize protein sequences without the slow trial-and-error of traditional lab cycles.
The platform utilizes large language models (LLMs) trained on over 1 billion protein sequences to suggest modifications that improve stability, activity, and binding affinity. By leveraging multi-objective optimization, scientists can simultaneously refine disparate traits like thermal resistance and catalytic efficiency. Cradle typically reduces the number of experimental rounds from 10 down to just 3, providing a verified research speedup of up to 12x.
Unlike traditional biotech partnerships, Cradle operates on a pure software subscription model with a zero-royalty policy. This ensures that organizations retain 100% of the intellectual property generated through the platform. Data is hosted in secure, private workspaces that meet SOC 2 and ISO 27001 standards, ensuring customer sequences are never used to train models for competitors.
Browser / Automation – Web Interface Toolchain – REST API for lab hardware integration
Capabilities – Enzyme engineering, antibody design, peptide optimization
Users maintain 100% ownership of all generated intellectual property.
Academic Tier: Contact for Quote - Tailored for not-for-profit research institutions. Standard Plan: Contact for Quote - Annual license based on the number of active projects. Enterprise Plan: Contact for Quote - Custom scaling for large multi-division organizations.
Discover Cradle and thousands of other AI tools on Beyond The AI - your trusted directory for AI solutions.